Related Experiment Video
Updated: May 17, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.5K
Lipid Lowering Agents and Late Life Cognitive Dysfunction.
Avi Stern1, Paul Teng1, William H Frishman2
1From the School of Medicine, New York Medical College, Valhalla, NY.
Cardiology in Review
|May 16, 2025
Summary
Dyslipidemia increases cardiovascular disease and cognitive decline risk. Lipid-lowering drugs, like statins, may offer neuroprotection, potentially reducing dementia risk by addressing dyslipidemia early.
Area of Science:
- Neuroscience
- Cardiology
- Pharmacology
Background:
- Dyslipidemia is a key risk factor for atherosclerosis and cardiovascular disease.
- Emerging evidence links dyslipidemia to cognitive decline and dementia.
- Current lipid-lowering treatments primarily target cardiovascular outcomes.
Purpose of the Study:
- To review literature on lipid-lowering agents and their potential role in mitigating late-life cognitive decline.
- To explore the neuroprotective benefits of statins, ezetimibe, and bile acid sequestrants.
- To emphasize the importance of early dyslipidemia treatment for cognitive health.
Main Methods:
- Literature review of existing studies.
- Analysis of research on prominent lipid-lowering agents.
- Focus on studies assessing cognitive outcomes and neuroprotection.
Main Results:
- Lipid-lowering agents may have a role in reducing the risk of cognitive dysfunction.
- Statins, ezetimibe, and bile acid sequestrants show potential for neuroprotection.
- Early intervention for dyslipidemia might be crucial for long-term brain health.
Conclusions:
- Lipid-lowering therapies warrant consideration for their potential to reduce cognitive decline.
- Further research is needed to fully elucidate the neuroprotective effects of these agents.
- Addressing dyslipidemia early may be a viable strategy for preserving cognitive function.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
475
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
475
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
86
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
86
01:22Alzheimer's Disease: Treatment
133
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
133
01:30Cognitive Development During Adulthood
34
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
34
01:26Alzheimer's Disease: Overview
350
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
350
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
108
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
108